Related Experiment Video
Updated: Jun 27, 2026

05:58
Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Quality assessment in point-of-care coagulation testing
Dianne P Kitchen1, Steve Kitchen, Ian Jennings
1UK NEQAS Blood Coagulation, Sheffield, UK. dianne.kitchen@coageqa.org.uk
Seminars in Thrombosis and Hemostasis
|December 17, 2008
Summary
Point-of-care (POC) testing for hemostasis, including international normalized ratio (INR) monitoring, is growing globally. This review covers quality control for POC devices and presents data from external quality assessment exercises.
Area of Science:
- Clinical diagnostics
- Medical devices
- Hematology
Background:
- Point-of-care (POC) testing in hemostasis is rapidly expanding worldwide.
- Applications include operating theaters and monitoring oral anticoagulant therapy using international normalized ratio (INR) devices.
- Quality control and assessment are critical for POC hemostasis devices.
Purpose of the Study:
- To review issues related to internal quality control and external quality assessment for POC hemostasis devices.
- To describe data from external quality assessment (EQA) exercises for POC-INR devices.
- To present the use of split samples comparing POC devices with conventional laboratory methods.
Main Methods:
- Review of quality control and external quality assessment principles for POC hemostasis testing.
- Analysis of data from EQA exercises involving multiple POC-INR device users.
- Comparison of patient samples analyzed by POC devices and conventional laboratory methods using split samples.
Main Results:
- External quality assessment data from various POC-INR devices were analyzed.
- Split sample analysis demonstrated the performance of POC devices against laboratory standards.
- The study highlights the importance of robust quality control measures for POC hemostasis testing.
Conclusions:
- POC hemostasis testing, particularly INR monitoring, requires rigorous quality control and external assessment.
- EQA data and split sample analyses are essential for validating POC device performance.
- Ensuring accuracy and reliability of POC devices is crucial for patient management in anticoagulant therapy.
Related Concept Videos
Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

